Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Drug Delivery To Osteoclast Receptor Targets
Published 2009 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
This paper references
Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling
A. Tee (2002)
TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells*
B. Wong (1997)
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.
R. Marx (2003)
Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1.
S. Srivastava (1998)
Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells.
S. Wada (1995)
Streptavidin in antibody pretargeting. 2. Evaluation Of methods for decreasing localization of streptavidin to kidney while retaining its tumor binding capacity.
D. Wilbur (1998)
Interaction of PTH and PTHrP with Their Receptors
T. Gardella (2004)
Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts.
K. Mchugh (2000)
Vav3 regulates osteoclast function and bone mass
R. Faccio (2005)
Akt regulates growth by directly phosphorylating Tsc2
C. Potter (2002)
Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib
T. Mashiba (2000)
Mice Lacking the Integrin β5 Subunit Have Accelerated Osteoclast Maturation and Increased Activity in the Estrogen‐Deficient State
N. Lane (2005)
Esophagitis associated with the use of alendronate.
P. D. de Groen (1996)
Patient responsiveness to calcitonin salmon nasal spray: a subanalysis of a 2-year study.
K. Overgaard (1995)
Catalytic Properties of ADAM19*
V. Chesneau (2003)
TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption
Byoung S. Kwon (1998)
The role of cell seeding density and nutrient supply for articular cartilage tissue engineering with deformational loading.
R. Mauck (2003)
Osteonal and hemi‐osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone
A. Parfitt (1994)
Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts.
K. Fuller (1995)
Alternative RNA processing--its role in regulating expression of calcitonin/calcitonin gene-related peptide.
H. Lou (1998)
A cloned porcine renal calcitonin receptor couples to adenylyl cyclase and phospholipase C.
T. Force (1992)
RANK/RANKL: Regulators of Immune Responses and Bone Physiology
A. Leibbrandt (2008)
Effect of aging on the toughness of human cortical bone: evaluation by R-curves.
R. K. Nalla (2004)
Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation.
A. Reszka (2001)
Diagnosis of osteoporosis in men, premenopausal women, and children.
Vinculin, talin, and integrins are localized at specific adhesion sites of malignant B lymphocytes
P. Marchisio (1988)
A recombinant calcitonin receptor independently stimulates 3',5'-cyclic adenosine monophosphate and Ca2+/inositol phosphate signaling pathways.
O. Chabre (1992)
Bone resorption by isolated osteoclasts in living versus devitalized bone: Differences in mode and extent and the effects of human recombinant tissue inhibitor of metalloproteinases
H. Shimizu (1990)
Diagnosis, screening, prevention, and treatment of osteoporosis.
K. Mauck (2006)
Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody.
M. Zhang (1997)
Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.
R. Siegel (2000)
Association of oestrogen receptor α gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone
O. Albagha (2005)
The morphological association between microcracks and osteocyte lacunae in human cortical bone.
S. Qiu (2005)
Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts.
S. Wada (1997)
Minireview: Insights into G protein-coupled receptor function using molecular models.
M. Gershengorn (2001)
Osteoporosis in men.
J. M. Campion (2003)
Negative Regulation of Osteoclastogenesis by Ectodomain Shedding of Receptor Activator of NF-κB Ligand*
Atsuhiko Hikita (2006)
RANK Overexpression in Transgenic Mice with Mouse Mammary Tumor Virus Promoter-Controlled RANK Increases Proliferation and Impairs Alveolar Differentiation in the Mammary Epithelia and Disrupts Lumen Formation in Cultured Epithelial Acini
Eva González-Suárez (2006)
TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells.
R. Josien (1999)
Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element.
D. Ignar-Trowbridge (1993)
Increasing sex difference in bone strength in old age: The Age, Gene/Environment Susceptibility-Reykjavik study (AGES-REYKJAVIK).
G. Sigurdsson (2006)
Osteoclast differentiation and activation
W. Boyle (2003)
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.
H. Yasuda (1998)
The Contribution of Trabecular Architecture to Cancellous Bone Quality
D. Dempster (2000)
MFR, a Putative Receptor Mediating the Fusion of Macrophages
C. Saginario (1998)
Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein.
O. Destaing (2003)
Vascular endothelial-cadherin regulates cytoskeletal tension, cell spreading, and focal adhesions by stimulating RhoA.
C. Nelson (2004)
Perturbed sex steroid status in men with idiopathic osteoporosis and their sons.
I. van Pottelbergh (2004)
Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.
S. Aronica (1993)
Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways.
M. Zaidi (1990)
Ultrastructural effects of calcitonin on osteoclasts in tissue culture.
D. M. Kallio (1972)
Osteoclastic bone resorption by a polarized vacuolar proton pump.
H. Blair (1989)
Evidence for calcitonin--a new hormone from the parathyroid that lowers blood calcium.
D. Copp (1962)
Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS.
P. Ralph (1977)
Calcitonin treatment in osteoectasia with hyperphosphatasia (juvenile Paget's disease): radiographic changes after treatment
B. Tüysüz (1999)
TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival Factor
B. Wong (1997)
Preparation of a monoclonal antibody directed against the receptor for murine colony-stimulating factor-1.
R. Shadduck (1993)
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ
H. Takayanagi (2000)
The calcitonin exon and its flanking intronic sequences are sufficient for the regulation of human calcitonin/calcitonin gene-related peptide alternative RNA splicing.
H. Lou (1994)
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
Y. Kong (1999)
Osteoclastic Tartrate-resistant Acid Phosphatase (Acp 5): Its Localization to Dendritic Cells and Diverse Murine Tissues
A. R. Hayman (2000)
Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation
D. Lacey (1998)
Cooperation of 5' and 3' processing sites as well as intron and exon sequences in calcitonin exon recognition.
H. Zandberg (1995)
Calcitonin alters behaviour of isolated osteoclasts
T. Chambers (1982)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K. Inoki (2002)
Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.
R. Kitazawa (1994)
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
Y. Kong (1999)
Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats.
T. Shinki (1999)
Crystal Structure of the Extracellular Domain of Mouse RANK Ligand at 2.2-Å Resolution*
S. Ito (2002)
Signaling by the TNF receptor superfamily and T cell homeostasis.
K. F. Chan (2000)
Regulation of Mucosal Dendritic Cell Function by Receptor Activator of NF-κB (RANK)/RANK Ligand Interactions: Impact on Tolerance Induction
E. Williamson (2002)
Biphasic effect of calcitonin on tartrate‐resistant acid phosphatase activity in isolated rat osteoclasts
S. Yumita (1991)
Regional Differences in Intestinal Spreading and pH Recovery and the Impact on Salmon Calcitonin Absorption in Dogs
Y. Lee (2004)
Mechanotransduction and strain amplification in osteocyte cell processes.
Y. Han (2004)
A brief history of calcitonin
E. Colman (2002)
DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk.
W. Zou (2008)
A selective inhibitor of the osteoclastic V-H(+)-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats.
L. Visentin (2000)
Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa).
L. Widler (2002)
The diagnosis of osteoporosis
J. Kanis (1992)
The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women.
A. Grey (1995)
New and emerging treatments for osteoporosis
M. Maricic (2007)
Strontium ranelate for preventing and treating postmenopausal osteoporosis.
S. O'Donnell (2006)
New Bisphosphonates in the Treatment of Bone Diseases
D. Gatti (1999)
Pharmacologic profile of zoledronic acid: A highly potent inhibitor of bone resorption
J. Green (2002)
K. Matsuo (2008)
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial
M. Bolland (2008)
Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts.
H. Palokangas (1997)
A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.
V. W. Engleman (1997)
Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts.
K. Insogna (1997)
CD47, a Ligand for the Macrophage Fusion Receptor, Participates in Macrophage Multinucleation*
X. Han (2000)
Multiple domains interacting with Gs in the porcine calcitonin receptor.
P. Orcel (2000)
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
D. Anderson (1997)
Endocrinology: Bone adaptation requires oestrogen receptor-α
K. Lee (2003)
Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption.
B. Moonga (1990)
The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene
H. Yoshida (1990)
Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities
J. Delaissé (2003)
Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivo
H. Fleisch (1969)
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
F. Arai (1999)
Cellular survival: a play in three Akts.
S. Datta (1999)
Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men.
I. Reid (2008)
Constitutive receptor systems for drug discovery.
G. Chen (1999)
Segregation of TRAF6‐mediated signaling pathways clarifies its role in osteoclastogenesis
N. Kobayashi (2001)
Downregulation of Small GTPase Rab7 Impairs Osteoclast Polarization and Bone Resorption* 210
H. Zhao (2001)
Osteopetrosis in mice lacking NF-κB1 and NF-κB2
V. Iotsova (1997)
Stable Association of PYK2 and p130Cas in Osteoclasts and Their Co-localization in the Sealing Zone*
P. Lakkakorpi (1999)
Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
K. Väänänen (2005)
Macrophage fusion: are somatic and cancer cells possible partners?
A. Vignery (2005)
Effect of vitamin D3 on duodenal calcium absorption in vivo during early development.
L. A. Dostal (1984)
Receptor classification: post genome.
S. Foord (2002)
Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects.
Xu-Ming Dai (2002)
The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology
R. Locksley (2001)
Structural characteristics of cross-linking sites in type V collagen of bone. Chain specificities and heterotypic links to type I collagen.
C. Niyibizi (1994)
Molecular mechanisms of action of steroid/thyroid receptor superfamily members.
M. Tsai (1994)
Osteoporosis: trends and intervention.
A. Inzerillo (2002)
Wortmannin, a specific inhibitor of phosphatidylinositol‐3 kinase, blocks osteoclastic bone resorption
I. Nakamura (1995)
Relations between histologic indices of bone formation: Implications for the pathogenesis of spinal osteoporosis
A. Parfitt (1995)
Role of c‐Src in cellular events associated with colony‐stimulating factor‐1‐induced spreading in osteoclasts
K. Insogna (1997)
Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome.
H. Rico (1992)
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
M. Yagi (2005)
Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones
M. Engsig (2000)
Pharmacokinetic disposition of polyethylene glycol-modified salmon calcitonins in rats.
S. Yoo (2000)
Role of Transmembrane 4 Superfamily (Tm4sf) Proteins Cd9 and Cd81 in Muscle Cell Fusion and Myotube Maintenance
I. Tachibana (1999)
Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse.
W. Wiktor-Jedrzejczak (1990)
Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts
K. Fuller (1993)
Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers
E. Hauge (2001)
Expansile Skeletal Hyperphosphatasia: A New Familial Metabolic Bone Disease
M. Whyte (2000)
In Vivo Detection of Dendritic Cell Antigen Presentation to CD4+ T Cells
E. Ingulli (1997)
Genetic regulation of osteoclast development and function
S. Teitelbaum (2003)
Osteoclast lineage and function.
H. Väänänen (2008)
Microdamage: a cell transducing mechanism based on ruptured osteocyte processes.
J. Hazenberg (2006)
Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference.
S. Baim (2008)
Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells.
R. Pacifici (1991)
Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men.
S. Khosla (2004)
Phospholipase D- and protein kinase C isoenzyme-dependent signal transduction pathways activated by the calcitonin receptor.
F. Naro (1998)
Bisphosphonates - mechanisms of action
T. Martin (2000)
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
B. Ettinger (1999)
3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro
D. Alessi (1998)
Bone turnover markers and bone density across the menopausal transition.
P. Ebeling (1996)
Cell type-specific regulation of transcription by cyclic adenosine 3,'5'-monophosphate-responsive elements within the calcitonin promoter.
Y. T. Monla (1995)
Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males.
N. Sims (2002)
Idiopathic Hyperphosphatasia and TNFRSF11B Mutations: Relationships Between Phenotype and Genotype
Belinda Chong (2003)
Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: in vitro‐in vivo evaluation
S. T. Dogru (2000)
Mechanical design in organisms
D. Butler (1986)
Body composition changes with age have gender-specific impacts on bone mineral density.
S. Lim (2004)
Severe osteopetrosis, defective interleukin‐1 signalling and lymph node organogenesis in TRAF6‐deficient mice
A. Naito (1999)
Colonic absorption of human calcitonin in man.
K. Antonin (1992)
Determination of Three Isoforms of the Receptor Activator of Nuclear Factor-κΒ Ligand and Their Differential Expression in Bone and Thymus.
T. Ikeda (2001)
Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity.
J. Lam (2001)
PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2.
D. Mao (2006)
The sensitivity of isolated osteoclasts to morphological transformation by calcitonin.
T. Chambers (1983)
Characterization of the Osteoclast Ruffled Border Chloride Channel and Its Role in Bone Resorption*
P. Schlesinger (1997)
Calcitonin and calcitonin receptors: bone and beyond
M. Pondel (2000)
Macrophage Colony-stimulating Factor Promotes Cell Survival through Akt/Protein Kinase B*
T. Kelley (1999)
Critical Role of β3 Integrin in Experimental Postmenopausal Osteoporosis
H. Zhao (2005)
Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells
K. Loser (2006)
SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts
S. Takeshita (2002)
Radiation-induced changes in gene expression and distribution of atrial natriuretic peptide (ANP) in different anatomical regions of the rat heart
J. C. Kruse (2002)
Bone quality--the material and structural basis of bone strength and fragility.
E. Seeman (2006)
The GTPase superfamily: conserved structure and molecular mechanism
H. Bourne (1991)
The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure.
H. Väänänen (1995)
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis
M. Asagiri (2005)
Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.
Y. Wittrant (2004)
Bone densitometry and clinical decision-making in osteoporosis.
B. Riggs (1988)
Osteoblasts release osteoclasts from calcitonin-induced quiescence.
T. Chambers (1982)
Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.
V. Kartsogiannis (1999)
What PROOF proves about calcitonin and clinical trials.
S. Cummings (2000)
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
C. Chesnut (2000)
Nonpeptide αvβ3 Antagonists. Part 11: Discovery and Preclinical Evaluation of Potent αvβ3 Antagonists for the Prevention and Treatment of Osteoporosis
P. Coleman (2004)
Myogenesis: A View from Drosophila
M. Baylies (1998)
Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase.
B. Darnay (1998)
Antitumor vaccine effect of irradiated murine neuroblastoma cells producing interleukin-2 or granulocyte macrophage-colony stimulating factor.
H. Yoshida (1998)
Plasma kinetics and urinary excretion of exogenous human and salmon calcitonin in man.
R. Huwyler (1979)
Osteoclast Ruffled Border Has Distinct Subdomains for Secretion and Degraded Matrix Uptake
M. Mulari (2003)
A review of anabolic therapies for osteoporosis
N. Lane (2003)
Loss of the ClC-7 Chloride Channel Leads to Osteopetrosis in Mice and Man
U. Kornak (2001)
U0126 and PD98059, Specific Inhibitors of MEK, Accelerate Differentiation of RAW264.7 Cells into Osteoclast-like Cells*
H. Hotokezaka (2002)
The calcitonin‐like sequence of the β CGRP gene
M. Alevizaki (1986)
RANKL-induced DC-STAMP Is Essential for Osteoclastogenesis
T. Kukita (2004)
Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization.
G. C. Nicholson (1986)
M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase
H. Glantschnig (2003)
Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam Study.
Hermien W Goderie-Plomp (2004)
Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice.
P. Schwartzberg (1997)
Requirement for NF-κB in osteoclast and B-cell development
G. Franzoso (1997)
The Many Faces of G Protein Signaling*
H. Hamm (1998)
Shared Principles in NF-κB Signaling
M. Hayden (2008)
Bone-Resorbing Cytokines from Peripheral Blood Mononuclear Cells after Hormone Replacement Therapy: A Longitudinal Study
O. Bernard-Poenaru (2001)
PTH, calcitonin, cyclic nucleotides and the kidney.
Z. Agus (1981)
Bone biology and the pathogenesis of osteoporosis
R. Russell (2006)
HISTOCHEMICAL DEMONSTRATION OF ACID PHOSPHATASE ACTIVITY IN OSTEOCLASTS
M. S. Burstone (1959)
Characterization of the structural and functional properties of cloned calcitonin receptor cDNAs.
S. Goldring (1993)
Absorption of human calcitonin across the rat colon in vivo.
J. Hastewell (1992)
Modulation of Transforming Growth Factor-β Production in Normal Human Osteoblast-Like Cells by 17β-Estradiol and Parathyroid Hormone
M. J. Oursler (1991)
Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse.
R. Felix (1990)
Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells.
R. Rotello (1991)
Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice.
J. M. Shipley (1996)
Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β
D. E. Hughes (1996)
Tetraspanin Protein CD9 Is a Novel Paranodal Component Regulating Paranodal Junctional Formation
T. Ishibashi (2004)
Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
W. Cheng (2008)
Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts.
T. Sato (1997)
Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025
R. Burge (2007)
Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mold dictyostelium discoideum
M. Rogers (1994)
The long and the short of bone therapy.
M. Whyte (2006)
Bone histomorphometry in vitamin D-deficient rats infused with calcium and phosphorus.
R. Weinstein (1984)
THE EFFECTS OF PARATHYROID HORMONE, COLCHICINE, AND CALCITONIN ON THE ULTRASTRUCTURE AND THE ACTIVITY OF OSTEOCLASTS IN ORGAN CULTURE
M. E. Holtrop (1974)
Oral Delivery of Mono-PEGylated sCT (Lys18) in Rats: Regional Difference in Stability and Hypocalcemic Effect
S. Mansoor (2005)
Bones: Structure and Mechanics
J. Currey (2002)
Modulation of osteoclast differentiation.
T. Suda (1992)
Identification of matrix metalloproteinase 9 in rabbit osteoclasts.
K. Tezuka (1994)
New mechanisms and targets in the treatment of bone fragility.
T. Martin (2007)
Biology of the Osteoclast
R. Baron (1993)
RANK is essential for osteoclast and lymph node development.
W. Dougall (1999)
Human Osteopetrosis and Other Sclerosing Disorders: Recent Genetic Developments
M. C. Vernejoul (2001)
Pivotal role of cathepsin K in lung fibrosis.
F. Bühling (2004)
Short‐term local injections of transforming growth factor‐β1 decrease ovariectomy‐stimulated osteoclastic resorption in vivo in rats
J. Beaudreuil (1995)
Female Estrogen Receptor β−/− Mice Are Partially Protected Against Age‐Related Trabecular Bone Loss
S. Windahl (2001)
The Bone Lining Cell: Its Role in Cleaning Howship's Lacunae and Initiating Bone Formation
V. Everts (2002)
Expansile Skeletal Hyperphosphatasia Is Caused by a 15‐Base Pair Tandem Duplication in TNFRSF11A Encoding RANK and Is Allelic to Familial Expansile Osteolysis
M. Whyte (2002)
Bisphosphonates: mechanisms of action and clinical use in osteoporosis--an update.
H. Fleisch (1997)
TRAF6 is a critical factor for dendritic cell maturation and development.
T. Kobayashi (2003)
Estrogen receptor null mice: what have we learned and where will they lead us?
J. F. Couse (1999)
A β1 integrin signaling pathway involving Src‐family kinases, Cbl and PI‐3 kinase is required for macrophage spreading and migration
F. Meng (1998)
The role of collagen in bone strength
S. Viguet-Carrin (2005)
The Chloride Channel Inhibitor NS3736 Prevents Bone Resorption in Ovariectomized Rats Without Changing Bone Formation
S. Schaller (2004)
Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency.
M. Weitzmann (2002)
NF-κB at the crossroads of life and death
M. Karin (2002)
Streptavidin-biotin crosslinking of therapeutic enzymes with carrier antibodies: nanoconjugates for protection against endothelial oxidative stress.
V. Shuvaev (2004)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
J. Rossouw (2002)
Hormonal regulation of acid phosphatase release by osteoclasts disaggregated from neonatal rat bone
T. Chambers (1987)
Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.
E. Tsuda (1997)
Structure-activity relationship of human calcitonin-gene-related peptide.
M. Zaidi (1990)
Further evidence for the origin of circulating calcitonin gene‐related peptide in the rat.
P. Emson (1989)
Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones.
L. Blavier (1995)
Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium.
A. Abou-Samra (1992)
Role of cytokines in bone resorption.
S. Manolagas (1995)
Normocalcemia without hyperparathyroidism in vitamin D‐deficient rats
U. Kollenkirchen (1991)
The pharmacology of bisphosphonates and new insights into their mechanisms of action
R. Russell (1999)
The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor*
B. Wong (1998)
Bone remodelling: its local regulation and the emergence of bone fragility.
T. Martin (2008)
Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae.
M. Rogers (1995)
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL.
C. Lynch (2005)
Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis
T. Koga (2004)
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.
J. Li (2000)
IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss
M. G. Ruocco (2005)
Effects of peptides from the calcitonin genes on bone and bone cells.
M. Zaidi (1988)
The acute biochemical effects of four proprietary calcium preparations.
I. Reid (1986)
The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis
T. Wada (2005)
The effect of intranasal salmon calcitonin on postmenopausal bone turnover as assessed by biochemical markers: Evidence of maximal effect after 8 weeks of continuous treatment
M. E. Kraenzlin (2006)
Intracolonic bioavailability of human calcitonin in man
C. Beglinger (2005)
An intron enhancer recognized by splicing factors activates polyadenylation.
H. Lou (1996)
Avidin-biotin technology : preparation of biotinylated probes.
E. Bayer (1992)
Pulmonary delivery of drugs for bone disorders.
J. S. Patton (2000)
Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD.
S. Srivastava (1999)
Pathogenesis of osteoporosis: concepts, conflicts, and prospects.
L. Raisz (2005)
Thyrocalcitonin: Inhibitor of Bone Resorption in Tissue Culture
J. Friedman (1965)
Acute antiosteoclastic effect of salmon calcitonin in osteoporotic women
Diana González (2007)
Lipeo-sCT: a novel reversible lipidized salmon calcitonin derivative, its biophysical properties and hypocalcemic activity.
W. Cheng (2009)
Granulocyte macrophage-colony stimulating factor reciprocally regulates alphav-associated integrins on murine osteoclast precursors.
M. Inoue (1998)
Calcitonin-dependent down-regulation of the mouse C1a calcitonin receptor in cells of the osteoclast lineage involves a transcriptional mechanism.
D. Inoue (1999)
Bisphosphonates: Mode of Action and Pharmacology
R. Russell (2007)
Sex steroids and bone.
S. Manolagas (2002)
A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
I. Reid (2004)
A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype.
T. Cundy (2002)
Assessment of fracture risk: who should be treated for osteoporosis?
M. van der Klift (2005)
Bone maintenance and remodeling: A control system based on fatigue damage
D. Taylor (1997)
TRANCE is a TNF family member that regulates dendritic cell and osteoclast function
B. Wong (1999)
A cell strain cultured from porcine kidney increases cyclic AMP content upon exposure to calcitonin or vasopressin.
S. Goldring (1978)
Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors.
C. Ulrich (1998)
The Deletion of 14 Amino Acids in the Seventh Transmembrane Domain of a Naturally Occurring Calcitonin Receptor Isoform Alters Ligand Binding and Selectively Abolishes Coupling to Phospholipase C*
J. Shyu (1996)
PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
L. Dương (1998)
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
H. Takayanagi (2007)
Forty years of calcitonin--where are we now? A tribute to the work of Iain Macintyre, FRS.
M. Zaidi (2002)
Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density
W. Simonet (1997)
Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
E. Barrett-connor (2006)
The Osteoclast Differentiation Factor Osteoprotegerin-Ligand Is Essential for Mammary Gland Development
J. Fata (2000)
The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer.
D. Russo (2007)
Effect of calcitonin on vertebral and other fractures.
J. Kanis (1999)
c-Fms and the αvβ3 integrin collaborate during osteoclast differentiation
R. Faccio (2003)
Down-regulation of calcitonin gene transcription by vitamin D requires two widely separated enhancer sequences.
S. Peleg (1993)
Tissue distribution of avidin and streptavidin injected to mice. Effect of avidin carbohydrate, streptavidin truncation and exogenous biotin.
B. Schechter (1990)
The steroid and thyroid hormone receptor superfamily.
R. Evans (1988)
B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.
T. Kawai (2006)
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.
M. A. Lomaga (1999)
Carotid artery plaque thickness is associated with increased serum calcium levels: the Northern Manhattan study.
M. Rubin (2007)
Expression of and Role for Ovarian Cancer G-protein-coupled Receptor 1 (OGR1) during Osteoclastogenesis*
Meiheng Yang (2006)
A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling.
F. K. Chan (2000)
Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells.
K. B. Tan (1997)
The Involvement of Multiple Tumor Necrosis Factor Receptor (TNFR)-associated Factors in the Signaling Mechanisms of Receptor Activator of NF-κB, a Member of the TNFR Superfamily*
L. Galibert (1998)
Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL
C. Sobacchi (2007)
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.
H. Takayanagi (2002)
Osteoclasts, integrins, and osteoporosis
S. Teitelbaum (2000)
Removal of osteoclast bone resorption products by transcytosis.
J. Salo (1997)
Comparison of reversible and nonreversible aqueous-soluble lipidized conjugates of salmon calcitonin.
W. Cheng (2008)
Identification of an inducible surface molecule specific to fusing macrophages.
C. Saginario (1995)
Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers
M. Gillespie (1997)
Osteoclast cell fusion: mechanisms and molecules
M. Ishii (2008)
Loss of Osteocyte Integrity in Association with Microdamage and Bone Remodeling After Fatigue In Vivo
O. Verborgt (2000)
Peptides from the calcitonin genes: molecular genetics, structure and function.
L. Breimer (1988)
Direct in vivo demonstration by radioautography of specific binding sites for calcitonin in skeletal and renal tissues of the rat
H. Warshawsky (1980)
PREVENTION OF SPINAL OSTEOPOROSIS IN OOPHORECTOMISED WOMEN
R. Lindsay (1980)
High-affinity androgen binding and androgenic regulation of alpha 1(I)-procollagen and transforming growth factor-beta steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells.
D. Benz (1991)
Acid Phosphatase Activity in Human Blood Cells
A. Goldberg (1962)
Calcitonin Receptor Regulation and Responsiveness to Calcitonin in Human Osteoclast-Like Cells Prepared in Vitro using Receptor Activator of Nuclear Factor-κB Ligand and Macrophage Colony-Stimulating Factor.
A. Samura (2000)
Randomized controlled trial of calcium in healthy older women.
I. Reid (2006)
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients.
G. Block (2007)